117 related articles for article (PubMed ID: 9459169)
21. Expression of glutathione s-transferase pi in benign mucosa, Barrett's metaplasia, and adenocarcinoma of the esophagus.
Chandra RK; Bentz BG; Haines GK; Robinson AM; Radosevich JA
Head Neck; 2002 Jun; 24(6):575-81. PubMed ID: 12112555
[TBL] [Abstract][Full Text] [Related]
22. The impact of schistosomiasis on the pathology of bladder carcinoma.
El-Bolkainy MN; Mokhtar NM; Ghoneim MA; Hussein MH
Cancer; 1981 Dec; 48(12):2643-8. PubMed ID: 7306921
[TBL] [Abstract][Full Text] [Related]
23. Expression of multidrug resistance 1 and glutathione-S-transferase-Pi protein in nasopharyngeal carcinoma.
Chen CL; Sheen TS; Lou IU; Huang AC
Hum Pathol; 2001 Nov; 32(11):1240-4. PubMed ID: 11727264
[TBL] [Abstract][Full Text] [Related]
24. Changes in expression and activity of glutathione S-transferase in different organs of schistosoma haematobium-infected hamster.
Sheweita SA; Mostafa MH; Ebid F; El-Sayed W
J Biochem Mol Toxicol; 2003; 17(3):138-45. PubMed ID: 12815609
[TBL] [Abstract][Full Text] [Related]
25. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M
Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092
[TBL] [Abstract][Full Text] [Related]
26. Glutathione S-transferase T1-1 activity upregulated in transitional cell carcinoma of urinary bladder.
Simic T; Mimic-Oka J; Savic-Radojevic A; Opacic M; Pljesa M; Dragicevic D; Djokic M; Radosavljevic R
Urology; 2005 May; 65(5):1035-40. PubMed ID: 15882759
[TBL] [Abstract][Full Text] [Related]
27. Limitations in the use of glutathione S-transferase P1 in urine as a marker for bladder cancer.
Lafuente A; Rodriguez A; Gibanel R; Lafuente MJ; Alonso M; Molina R; Ballesta A; Carretero P
Anticancer Res; 1998; 18(5B):3771-2. PubMed ID: 9854493
[TBL] [Abstract][Full Text] [Related]
28. Glutathione concentrations and glutathione S-transferase activity in human colonic neoplasms.
Butler RN; Butler WJ; Moraby Z; Fettman MJ; Khoo KK; Roberts-Thomson IC
J Gastroenterol Hepatol; 1994; 9(1):60-3. PubMed ID: 8155868
[TBL] [Abstract][Full Text] [Related]
29. Is glutathione-S-transferase-pi expression a reliable predictor of chemoradiation response in cancer of the head and neck?
Vural E; Alexiou M; Hunt J; Korourian S; Hanna E
Am J Otolaryngol; 2001; 22(4):257-60. PubMed ID: 11464322
[TBL] [Abstract][Full Text] [Related]
30. [Expression of glutathione S-transferase-pi in human esophageal squamous cell carcinoma].
Li Z; Zhang R; Luo X
Zhonghua Zhong Liu Za Zhi; 2001 Jan; 23(1):39-42. PubMed ID: 11783067
[TBL] [Abstract][Full Text] [Related]
31. Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines.
Hour TC; Chen J; Huang CY; Guan JY; Lu SH; Hsieh CY; Pu YS
Anticancer Res; 2000; 20(5A):3221-5. PubMed ID: 11062746
[TBL] [Abstract][Full Text] [Related]
32. Glutathione and glutathione S-transferases in human squamous cell carcinomas of the larynx and GSTM1 dependent risk.
Lafuente A; Maristany M; Arias C; Cuchi A; Lafuente MJ; Molina R; Ballesta A; Trasserra J
Anticancer Res; 1998; 18(1A):107-11. PubMed ID: 9568063
[TBL] [Abstract][Full Text] [Related]
33. Effect of glutathione and its related enzymes on chemosensitivity of renal cell carcinoma and bladder carcinoma cell lines.
Ahn H; Lee E; Kim K; Lee C
J Urol; 1994 Jan; 151(1):263-7. PubMed ID: 8254825
[TBL] [Abstract][Full Text] [Related]
34. Main drug- and carcinogen-metabolizing enzyme systems in human non-small cell lung cancer and peritumoral tissues.
Toussaint C; Albin N; Massaad L; Grunenwald D; Parise O; Morizet J; Gouyette A; Chabot GG
Cancer Res; 1993 Oct; 53(19):4608-12. PubMed ID: 8402635
[TBL] [Abstract][Full Text] [Related]
35. Expression of xenobiotic metabolizing enzymes in tumours of the urinary bladder.
Murray GI; Taylor VE; McKay JA; Weaver RJ; Ewen SW; Melvin WT; Burke MD
Int J Exp Pathol; 1995 Aug; 76(4):271-6. PubMed ID: 7547441
[TBL] [Abstract][Full Text] [Related]
36. Immunological reaction to bilharzial carcinoma of urinary bladder.
Aly MA; el-Makhzangy MI; el-Adl M; Essa MH
J Egypt Soc Parasitol; 1988 Dec; 18(2):697-703. PubMed ID: 3418166
[No Abstract] [Full Text] [Related]
37. Glutathione S-transferase-pi expression and glutathione concentration in ovarian carcinoma before and after chemotherapy.
Cheng X; Kigawa J; Minagawa Y; Kanamori Y; Itamochi H; Okada M; Terakawa N
Cancer; 1997 Feb; 79(3):521-7. PubMed ID: 9028363
[TBL] [Abstract][Full Text] [Related]
38. Plasma glutathione S-transferase pi 1-1 AND alpha 1-1 levels in patients with bladder cancer.
Berendsen CL; Mulder TP; Peters WH
J Urol; 2000 Dec; 164(6):2126-8. PubMed ID: 11061940
[TBL] [Abstract][Full Text] [Related]
39. Glutathione S-transferase and multidrug-resistant phenotype in transitional cell carcinoma of the bladder.
Akdaş A; Türkeri LN; Küllü S; Tarcan T; Sakr W; Grignon DJ
Eur Urol; 1996; 29(4):483-6. PubMed ID: 8791059
[TBL] [Abstract][Full Text] [Related]
40. Carcinoma of the bilharzial urinary bladder. A study of the associated mucosal lesions in 86 cases.
Khafagy MM; el-Bolkainy MN; Mansour MA
Cancer; 1972 Jul; 30(1):150-9. PubMed ID: 5040739
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
